Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 54 (RPSAP54) is a processed pseudogene closely resembling the functional ribosomal protein SA gene (RPSA). RPSA encodes a multifunctional protein known for roles in ribosomal assembly, cell adhesion, cancer progression, and as a receptor for various pathogens. RPSAP54, however, is one of several pseudogenes within the RPSA gene family. Pseudogenes, including RPSAP54, typically result from duplication or retrotransposition events and are usually non-functional, lacking protein-coding ability due to the presence of disruptive mutations or absence of regulatory elements necessary for expression. There is no evidence that RPSAP54 itself is expressed or participates in physiological or pathological processes.\n\nRPSAP54 is not a therapeutic target, enzyme, transporter, or receptor; it is a non-coding pseudogene. There is no evidence for biological activity, disease involvement, or drug interactions specific to RPSAP54. RPSAP54 may complicate genetic studies of RPSA due to high sequence similarity, necessitating careful experimental design but does not constitute a functional molecular target. The correct canonical target related to biological functions and disease processes would be Ribosomal protein SA (RPSA), not RPSAP54. If structured information for drug discovery or targeting is needed, focus should be on Ribosomal protein SA (RPSA, LRP/LR/67LR), not its pseudogene RPSAP54.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 54 (RPSAP54).